Medical Health Cluster


More Antibodies With Longer Intervals Between COVID Vaccine Doses

LISBON, Portugal — An overall ninefold increase in COVID-19 antibody levels can be seen with a longer interval between first and second doses of the Pfizer/BioNTech (BNT162b2) vaccine in people without prior infection, according to data from the UK government’s SIREN (SARS-CoV-2 Immunity and Reinfection Evaluation) study. This interval-dependent antibody […]

Read More

Fractionating COVID-19 Vaccine Doses May Save Lives

Administering smaller doses of COVID-19 vaccines could be economically viable and could save more lives than either full-dose vaccination or no vaccination in low- and middle-income countries (LMICs)—even with the emergence of new, more highly transmissible variants, according to a cost-effectiveness modeling study. Assuming a vaccine supply shortage, the study estimated […]

Read More

Federal Government Buys Thousands of Bebtelovimab Doses

The US Department of Health and Human Services (HHS) has purchased 600 000 treatment courses of bebtelovimab—a monoclonal antibody that research shows effectively treats the SARS-CoV-2 Omicron variant. Omicron is currently responsible for almost all COVID-19 cases in the US, according to an HHS statement. “We want to make sure if an […]

Read More

FDA to Consider Future of COVID Booster Doses

The FDA today announced its vaccines advisory committee will meet April 6 to discuss the future of COVID-19 booster doses and how to tell if a specific strain of the coronavirus needs its own vaccine. The independent experts on the Vaccines and Related Biological Products Advisory Committee will be joined by representatives […]

Read More